Table 1 The clinical information between GBS+ and control groups
From: Deviations in the gut microbiota of neonates affected by maternal group B Streptococcus colonization
Parameters | GBS + group (n = 13) | Control group (n = 73) | OR (95%CI) | P value |
|---|---|---|---|---|
Neonatal features | ||||
Gestational age, W | 39.5 ± 0.6 | 38.8 ± 1.9 | – | 0.009 |
Birth weight, g | 3192 ± 218 | 3121 ± 515 | – | 0.4 |
Male, (n, %) | 8 (61.5) | 39 (53.4) | 1.4 (0.4 ~ 4.7) | 0.6 |
Cesarean section (n, %) | 2 (15.4) | 30 (41.1) | 0.3 (0.05 ~ 1.3) | 0.1 |
Antibiotics exposure | 10 (76.9) | 30 (41.1) | 4.8 (1.2 ~ 18.8) | 0.017 |
Mother complication | ||||
PROM (n, %) | 2 (15.4) | 17 (23.3) | 0.6 (0.1 ~ 2.9) | 0.8 |
Intrapartum fever history | 0 (0) | 7 (9.6) | 0.8 (0.8 ~ 0.9) | 0.5 |
GDM (n, %) | 1 (7.7) | 27 (37.0) | 0.1 (0.02 ~ 1.15) | 0.07 |
Placental abruption | 0 (0) | 1 (1.4) | – | 1.0# |
MSAF (n, %) | 1 (7.7) | 23 (31.5) | 0.2 (0.02 ~ 1.44) | 0.1 |
IAP exposure | 11 (84.6) | 44 (60.3) | 3.6 (0.7 ~ 17.6) | 0.17 |